Seventure Partners has held the first close of its second microbiome fund. The Novartis-backed fund is more than halfway to its €200 million ($227 million)-plus fundraising target, setting up Seventure to invest in around 20 microbiome startups.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,